Clin Exp Otorhinolaryngol.  2008 Dec;1(4):177-183.

Significance of Susceptible Gene Expression Profiles in Nasal Polyposis

• Wang DY

Abstract

Nasal polyposis (NP) is a common chronic inflammatory disease of the rhinosinus mucosa and a complex disease with strong genetic and environmental components. During the past 10 to 20 yr, many studies have been performed to determine differential gene expression profiles between NP and normal nasal tissues, in order to identify susceptible genes that are associated with NP-related traits. Despite achievement in the identification of candidate genes and their associated pathogenic pathways, the large challenges remain as the genetic and molecular alterations required for its development and progression are still unclear. Therefore, the development of novel, powerful tools for gene discovery, and a closer integration of genetics and medical biology would provide valuable insight into the pathogenesis of NP.

Keyword

Nasal polyposis; Genetics; Gene expression profile; Pathogenesis and pathophysiology; Susceptible genes and pathways

MeSH Terms

Achievement
Biology
Gene Expression
Genetic Association Studies
Mucous Membrane
Transcriptome

Reference

1. Bateman ND, Fahy C, Woolford TJ. Nasal polyps: still more questions than answers. J Laryngol Otol. 2003; 1. 117(1):1–9. PMID: 12590849.

2. Triglia JM, Nicollas R. Nasal and sinus polyposis in children. Laryngoscope. 1997; 7. 107(7):963–966. PMID: 9217140.

3. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007; (20):1–136. PMID: 17844873.

4. Hellquist HB. Nasal polyps update. Histopathology. Allergy Asthma Proc. 1996; Sep–Oct. 17(5):237–242. PMID: 8922142.

5. Rugina M, Serrano E, Klossek JM, Crampette L, Stoll D, Bebear JP, et al. Epidemiological and clinical aspects of nasal polyposis in France: the ORLI group experience. Rhinology. 2002; 6. 40(2):75–79. PMID: 12091997.

6. Greisner WA 3rd, Settipane GA. Hereditary factor for nasal polyps. Allergy Asthma Proc. 1996; Sep–Oct. 17(5):283–286. PMID: 8922148.

7. Lockey RF, Rucknagel DL, Vanselow NA. Familial occurrence of asthma, nasal polyps and aspirin intolerance. Ann Intern Med. 1973; 1. 78(1):57–63. PMID: 4682309.

8. Settipane GA. Asthma, aspirin intolerance and nasal polyps. N Engl Reg Allergy Proc. 1986; Jan–Feb. 7(1):32–37. PMID: 3475535.

9. Drake-Lee A. Nasal polyps in identical twins. J Laryngol Otol. 1992; 12. 106(12):1084–1085. PMID: 1487667.

10. Karjalainen J, Joki-Erkkila VP, Hulkkonen J, Pessi T, Nieminen MM, Aromaa A, et al. The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy. 2003; 5. 58(5):393–396. PMID: 12752325.

11. Yea SS, Yang YI, Park SK, Jang WH, Lee SS, Seog DH, et al. Interleukin-4 C-590T polymorphism is associated with protection against nasal polyps in a Korean population. Am J Rhinol. 2006; Sep–Oct. 20(5):550–553. PMID: 17063753.

12. Bussu F, Tiziano FD, Giorgio A, Pinto AM, De Corso E, Angelozzi C, et al. Argl6gly polymorphism of the beta2-adrenoceptor gene (ADRBeta2) as a susceptibility factor for nasal polyposis. Am J Rhinol. 2007; May–Jun. 21(3):378–382. PMID: 17621827.

13. Luxenberger W, Posch U, Berghold A, Hofmann T, Lang-Loidolt D. HLA patterns in patients with nasal polyposis. Eur Arch Otorhinolaryngol. 2000; 257(3):137–139. PMID: 10839486.

14. Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope. 2000; 3. 110(3 Pt 1):422–425. PMID: 10718431.

15. Fajardo-Dolci G, Solorio-Abreu J, Romero-Alvarez JC, Zavaleta-Villa B, Cerezo-Camacho O, Jimenez-Lucio R, et al. DQA1 and DQB1 association and nasal polyposis. Otolaryngol Head Neck Surg. 2006; 8. 135(2):243–247. PMID: 16890076.

16. Ramirez-Anguiano J, Yamamoto-Furusho JK, Barquera R, Beltran O, Granados J. Association of HLA-DR3 and HLA-DR4 with sinonasal polyposis in Mexican Mestizos. Otolaryngol Head Neck Surg. 2006; 7. 135(1):90–93. PMID: 16815190.

17. Liu Z, Kim J, Sypek JP, Wang IM, Horton H, Oppenheim FG, et al. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol. 2004; 10. 114(4):783–790. PMID: 15480316.

18. Wang X, Dong Z, Zhu DD, Guan B. Expression profile of immune-associated genes in nasal polyps. Ann Otol Rhinol Laryngol. 2006; 6. 115(6):450–456. PMID: 16805377.

19. Van Bruaene N, Perez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008; 6. 121(6):1435–1441. PMID: 18423831.

20. Ramanathan M Jr, Lee WK, Spannhake EW, Lane AP. Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol. 2008; Mar–Apr. 22(2):115–121. PMID: 18416964.

21. Baruah P, Trimarchi M, Dumitriu IE, Dellantonio G, Doglioni C, Rovere-Querini P, et al. Innate responses to Aspergillus: role of C1q and pentraxin 3 in nasal polyposis. Am J Rhinol. 2007; Mar–Apr. 21(2):224–230. PMID: 17424885.

22. Ramanathan M Jr, Lee WK, Dubin MG, Lin S, Spannhake EW, Lane AP. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol. 2007; Jan–Feb. 21(1):110–116. PMID: 17283572.

23. Figueiredo CR, Silva ID, Weckx LL. Inflammatory genes in nasal polyposis. Curr Opin Otolaryngol Head Neck Surg. 2008; 2. 16(1):18–21. PMID: 18197016.

24. Barekzi E, Roman J, Hise K, Georas S, Steinke JW. Lysophosphatidic acid stimulates inflammatory cascade in airway epithelial cells. Prostaglandins Leukot Essent Fatty Acids. 2006; 6. 74(6):357–363. PMID: 16725318.

25. Chen PH, Fang SY. The expression of human antimicrobial peptide LL-37 in the human nasal mucosa. Am J Rhinol. 2004; Nov–Dec. 18(6):381–385. PMID: 15706986.

26. Cheng YK, Hwang GY, Lin CD, Tsai MH, Tsai SW, Chang WC. Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients. Laryngoscope. 2006; 3. 116(3):417–422. PMID: 16540901.

27. Chen PH, Fang SY. Expression of human beta-defensin 2 in human nasal mucosa. Eur Arch Otorhinolaryngol. 2004; 5. 261(5):238–241. PMID: 14504864.

28. Pujols L, Mullol J, Alobid I, Roca-Ferrer J, Xaubet A, Picado C. Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. J Allergy Clin Immunol. 2004; 10. 114(4):814–819. PMID: 15480320.

29. Ohkawara Y, Lim KG, Xing Z, Glibetic M, Nakano K, Dolovich J, et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest. 1996; 4. 01. 97(7):1761–1766. PMID: 8601642.

30. Lee CH, Rhee CS, Min YG. Cytokine gene expression in nasal polyps. Ann Otol Rhinol Laryngol. 1998; 8. 107(8):665–670. PMID: 9716868.

31. Mullol J, Xaubet A, Gaya A, Roca-Ferrer J, Lopez E, Fernandez JC, et al. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy. 1995; 25(7):607–615. PMID: 8521179.

32. Finotto S, Ohno I, Marshall JS, Gauldie J, Denburg JA, Dolovich J, et al. TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol. 1994; 153(5):2278–2289. PMID: 8051424.

33. Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med. 1999; 160(1):291–296. PMID: 10390414.

34. Yamada T, Fujieda S, Yanagi S, Yamamura H, Inatome R, Yamamoto H, et al. IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines. J Immunol. 2001; 167(1):283–288. PMID: 11418661.

35. Yamada T, Fujieda S, Yanagi S, Yamamura H, Inatome R, Sunaga H, et al. Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production. J Immunol. 2001; 166(1):538–543. PMID: 11123334.

36. Zaravinos A, Bizakis J, Spandidos DA. RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae. Cancer Lett. 2008; 6. 18. 264(2):288–298. PMID: 18329792.

37. Gevaert P, Bachert C, Holtappels G, Novo CP, Van der Heyden J, Fransen L, et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy. 2003; 5. 58(5):371–379. PMID: 12752323.

38. Hao J, Pang YT, Wang DY. Diffuse mucosal inflammation in nasal polyps and adjacent middle turbinate. Otolaryngol Head Neck Surg. 2006; 2. 134(2):267–275. PMID: 16455376.

39. Jareoncharsri P, Bunnag C, Tunsuriyawrong P, Assasin P, Muangsomboon S. Clinical and histopathological classification of nasal polyps in Thais. Siriraj Hosp Gaz. 2002; 54:689–697.

40. Zhang N, Holtappels G, Claeys C, Huang G, van Cauwenberge P, Bachert C. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol. 2006; Jul–Aug. 20(4):445–450. PMID: 16955777.

41. Meyer JE, Bartels J, Gorogh T, Sticherling M, Rudack C, Ross DA, et al. The role of RANTES in nasal polyposis. Am J Rhinol. 2005; Jan–Feb. 19(1):15–20. PMID: 15794069.

42. Bartels J, Maune S, Meyer JE, Kulke R, Schluter C, Rowert J, et al. Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression. Rhinology. 1997; 12. 35(4):171–174. PMID: 9532637.

43. Davidsson A, Danielsen A, Viale G, Olofsson J, Dell'Orto P, Pellegrini C, et al. Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Clinical relevance and relation to allergy. Acta Otolaryngol. 1996; 7. 116(4):604–610. PMID: 8831850.

44. Chen YS, Langhammer T, Westhofen M, Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Allergy. 2007; 1. 62(1):66–72. PMID: 17156344.

45. Choi BR, Kwon JH, Gong SJ, Kwon MS, Cho JH, Kim JH, et al. Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps. Exp Mol Med. 2006; 10. 31. 38(5):466–473. PMID: 17079862.

46. Yue J, Chen J, Kong W, Tan H, Shu H, Shi Q. The concentration and expression of IL-4, IL-5, IL-6, IL-8 in human nasal polyps tissues. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006; 6. 20(11):484–486. PMID: 16929824.

47. Guan GM, Dong Z, Lu M. Expression of aquaporin-1 and Bcl-2 mRNA in eosinophils of the nasal polyps and its significance. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004; 8. 39(8):476–478. PMID: 15563082.

48. Li M, Dong Z, Yang Z, Bai Y. Protein kinase C in proliferation and infiltration of eosinophils in nasal polyp. Chin Med J (Engl). 2003; 10. 116(10):1553–1556. PMID: 14570622.

49. Molinaro RJ, Bernstein JM, Koury ST. Localization and quantitation of eotaxin mRNA in human nasal polyps. Immunol Invest. 2003; 8. 32(3):143–154. PMID: 12916705.

50. Shin SH, Park JY, Jeon CH, Choi JK, Lee SH. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope. 2000; 8. 110(8):1353–1357. PMID: 10942140.

51. Cardell LO, Bogefors J, Bjartell A, Adner M, Uddman R, Egesten A. Topical steroids do not downregulate expression of growth-related oncogene-alpha in nasal polyps. Acta Otolaryngol. 2006; 4. 126(4):375–380. PMID: 16608789.

52. Kim YK, Nakagawa N, Nakano K, Sulakvelidze I, Dolovich J, Denburg J. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids. J Allergy Clin Immunol. 1997; 9. 100(3):389–399. PMID: 9314353.

53. Shun CT, Lin SK, Hong CY, Kok SH, Juan YH, Wang CC, et al. C-C chemokine ligand 2 gene expression in nasal polyp fibroblasts: possible implication in the pathogenesis of nasal polyposis. Ann Otol Rhinol Laryngol. 2005; 11. 114(11):879–885. PMID: 16358608.

54. Liu B, Wu J, Fan J, Peng Y. Gene expression profiles in human nasal polyps studied by DNA microarray. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008; 6. 22(11):495–497. PMID: 18727517.

55. Qiu ZF, Han DM, Zhang L, Zhang W, Fan EZ, Cui SJ, et al. Expression of survivin and enhanced polypogenesis in nasal polyps. Am J Rhinol. 2008; Mar–Apr. 22(2):106–110. PMID: 18336724.

56. Kim TH, Lee HM, Lee SH, Kim HK, Lee JH, Oh KH. Down-regulation of carbonic anhydrase isoenzymes in nasal polyps. Laryngoscope. 2008; 10. 118(10):1856–1861. PMID: 18622311.

57. Ding GQ, Zheng CQ, Bagga SS. Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis. Arch Otolaryngol Head Neck Surg. 2007; 11. 133(11):1097–1103. PMID: 18025312.

58. Rho HS, Lee SH, Lee HM, Jung HH, Choi J, Park MK, et al. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps. Arch Otolaryngol Head Neck Surg. 2006; 9. 132(9):985–989. PMID: 16982975.

59. Dong Z, Guan G, Chang W. Expression of cell proliferation and apoptosis gene associated protein on nasal polyps and its significance. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2000; 12. 35(6):429–431. PMID: 12768752.

60. Powers MR, Qu Z, LaGesse PC, Liebler JM, Wall MA, Rosenbaum JT. Expression of basic fibroblast growth factor in nasal polyps. Ann Otol Rhinol Laryngol. 1998; 10. 107(10 Pt 1):891–897. PMID: 9794621.

61. Ishibashi T, Tanaka T, Nibu K, Ishimoto S, Kaga K. Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol. 1998; 10. 107(10 Pt 1):885–890. PMID: 9794620.

62. Ingle RR, Setzen G, Koltai PJ, Monte D, Pastore J, Jennings TA. p53 protein expression in benign lesions of the upper respiratory tract. Arch Otolaryngol Head Neck Surg. 1997; 3. 123(3):297–300. PMID: 9076236.

63. Martinez-Anton A, Debolos C, Garrido M, Roca-Ferrer J, Barranco C, Alobid I, et al. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa. Clin Exp Allergy. 2006; 4. 36(4):448–457. PMID: 16630149.

64. Ali MS, Wilson JA, Bennett M, Pearson JP. Mucin gene expression in nasal polyps. Acta Otolaryngol. 2005; 6. 125(6):618–624. PMID: 16076710.

65. Young Kim J, Kim CH, Kim KS, Choi YS, Lee JG, Yoon JH. Extracellular signal-regulated kinase is involved in tumor necrosis factor-alpha-induced MUC5AC gene expression in cultured human nasal polyp epithelial cells. Acta Otolaryngol. 2004; 10. 124(8):953–957. PMID: 15513533.

66. Kim CH, Song KS, Kim SS, Kim HU, Seong JK, Yoon JH. Expression of MUC5AC mRNA in the goblet cells of human nasal mucosa. Laryngoscope. 2000; 12. 110(12):2110–2113. PMID: 11129031.

67. Bai CH, Song SY, Kim YD. Effect of glucocorticoid on the MUC4 gene in nasal polyps. Laryngoscope. 2007; 12. 117(12):2169–2173. PMID: 17891050.

68. Ding GQ, Zheng CQ. The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis. Am J Rhinol. 2007; May–Jun. 21(3):359–366. PMID: 17621824.

69. Burgel PR, Escudier E, Coste A, Dao-Pick T, Ueki IF, Takeyama K, et al. Relation of epidermal growth factor receptor expression to goblet cell hyperplasia in nasal polyps. J Allergy Clin Immunol. 2000; 10. 106(4):705–712. PMID: 11031341.

70. Fang SY, Yang BC. Overexpression of Fas-ligand in human nasal polyps. Ann Otol Rhinol Laryngol. 2000; 3. 109(3):267–270. PMID: 10737309.

71. Ito A, Hirota S, Mizuno H, Kawasaki Y, Takemura T, Nishiura T, et al. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathol Int. 1995; 10. 45(10):715–720. PMID: 8563931.

72. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, Woolley K, et al. Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma. Am J Respir Cell Mol Biol. 1995; 12. 13(6):639–647. PMID: 7576701.

73. Zaravinos A, Soufla G, Bizakis J, Spandidos DA. Expression analysis of VEGFA, FGF2, TGFbeta1, EGF and IGF1 in human nasal polyposis. Oncol Rep. 2008; 2. 19(2):385–391. PMID: 18202785.

74. Lee SH, Park JH, Oh BH, Jung KY, Lee HM, Choi JO, et al. Analysis of proteoglycan gene messages in human nasal mucosa and nasal polyp using dot blot hybridization. Acta Otolaryngol. 2001; 4. 121(3):398–402. PMID: 11425208.

75. Richer SL, Truong-Tran AQ, Conley DB, Carter R, Vermylen D, Grammer LC, et al. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol. 2008; May–Jun. 22(3):228–234. PMID: 18588753.

76. Rostkowska-Nadolska B, Kapral M, Mazurek U, Gawron W, Pres K. Co-expression of the TGF-beta1 and TGF-beta2 isoforms in nasal polyps and in healthy mucosa. Postepy Hig Med Dosw (Online). 2007; 61:702–707. PMID: 18059253.

77. Figueiredo CR, Santos RP, Silva ID, Weckx LL. Microarray cDNA to identify inflammatory genes in nasal polyposis. Am J Rhinol. 2007; Mar–Apr. 21(2):231–235. PMID: 17424886.

78. Zaravinos A, Bizakis J, Soufla G, Sourvinos G, Spandidos DA. Mutations and differential expression of the ras family genes in human nasal polyposis. Int J Oncol. 2007; 11. 31(5):1051–1059. PMID: 17912430.

79. Stankovic KM, Goldsztein H, Reh DD, Platt MP, Metson R. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope. 2008; 5. 118(5):881–889. PMID: 18391768.

80. Fritz SB, Terrell JE, Conner ER, Kukowska-Latallo JF, Baker JR. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol. 2003; 12. 112(6):1057–1063. PMID: 14657858.

81. Watanabe S, Suzaki H. Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid. In Vivo. 2008; 22(1):37–42. PMID: 18396779.